Don't Rely on Pregnancy Letter Categories to Make Treatment Recommendations
August 2015
Pregnancy categories (A, B, C, D, X) will start to DISAPPEAR from Rx drug labels...due to new rules on reporting pregnancy and lactation risks.
It's been a long time coming...over 20 years since FDA's labeling change initiative began. Now it's finally starting to hit drug labels.
More relevant info to help with therapy decisions will replace the A, B, C, D, and X categories...because these "letters" oversimplify and don't consistently explain the degree of fetal risk.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote